DaVita Boosts Share Buyback Plan Authorization by $2 Billion Amid Dialysis Service Focus
ByAinvest
Wednesday, Aug 20, 2025 5:09 pm ET1min read
DVA--
DaVita Inc., a provider of dialysis services, has increased its share buyback authorization by $2 billion, bringing the total authorization to $4 billion. The company's net sales are primarily driven by its supply of dialysis services, which accounted for 95.7% of its revenue in 2024. DaVita operates 2,657 dialysis centers in the US and 509 abroad, serving nearly 280,100 patients globally.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet